SLAMF6 and neoplasm: It is likely that other NK activation receptors or other members of MICA/B such as ULBP1-4 and Letal, a recently identified NKG2D ligand [32,33], may also participate in NK-92 cell-mediated cytotoxic activity against MICA/B-negative tumor cell lines [21].